Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$1.33B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$985M |
| 3 |
Eli Lilly
LLY
|
+$901M |
| 4 |
Toronto Dominion Bank
TD
|
+$796M |
| 5 |
Blackrock
BLK
|
+$544M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$857M |
| 2 |
NVIDIA
NVDA
|
+$803M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$676M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$671M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$611M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.21% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.12% |
| 4 | Healthcare | 6.97% |
| 5 | Consumer Discretionary | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
VanEck Short High Yield Muni ETF
SHYD
$456M
| $1.13M | ﹤0.01% |
50,343
-3,397
| -6% | -$77K |
|
3302
Credo Technology Group
CRDO
$48.5B
| $1.13M | ﹤0.01% |
28,031
-2,799
| -9% | -$174K |
|
|
EPRX
3303
Eupraxia Pharmaceuticals
EPRX
$442M
| $1.13M | ﹤0.01% |
342,828
+59,683
| +21% | +$206K |
|
3304
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$334M
| $1.12M | ﹤0.01% |
22,523
-47,825
| -68% | -$2.54M |
|
3305
Genesco
GCO
$391M
| $1.12M | ﹤0.01% |
52,848
+7,042
| +15% | +$245K |
|
3306
indie Semiconductor
INDI
$995M
| $1.12M | ﹤0.01% |
551,007
+416,519
| +310% | +$1.45M |
|
3307
Red Rock Resorts
RRR
$3.76B
| $1.12M | ﹤0.01% |
25,835
-5,254
| -17% | -$249K |
|
3308
Vanguard US Minimum Volatility ETF
VFMV
$447M
| $1.12M | ﹤0.01% |
8,811
-168
| -2% | -$21K |
|
3309
Invesco Short Term Treasury ETF
TBLL
$2.85B
| $1.11M | ﹤0.01% |
10,553
-1,147
| -10% | -$121K |
|
|
IAUX
3310
i-80 Gold Corp
IAUX
$1.45B
| $1.11M | ﹤0.01% |
1,913,377
-328,183
| -15% | -$212K |
|
3311
Vaxcyte
PCVX
$8.64B
| $1.11M | ﹤0.01% |
29,471
+15,774
| +115% | +$1.26M |
|
3312
Quanterix
QTRX
$122M
| $1.11M | ﹤0.01% |
170,745
+35,509
| +26% | +$296K |
|
3313
iShares MSCI Hong Kong ETF
EWH
$1.21B
| $1.11M | ﹤0.01% |
63,451
-16,890
| -21% | -$288K |
|
3314
Invesco S&P MidCap 400 Pure Growth ETF
RFG
$364M
| $1.11M | ﹤0.01% |
25,319
+107
| +0.4% | +$5.12K |
|
3315
Middleby
MIDD
$5.33B
| $1.11M | ﹤0.01% |
7,295
-125,314
| -94% | -$19.7M |
|
|
NCZ
3316
Virtus Convertible & Income Fund II
NCZ
$308M
| $1.11M | ﹤0.01% |
95,896
-3,314
| -3% | -$41.4K |
|
3317
Trupanion
TRUP
$1.34B
| $1.11M | ﹤0.01% |
29,763
+11,233
| +61% | +$467K |
|
|
LCDS
3318
JPMorgan Fundamental Data Science Large Core ETF
LCDS
$16.8M
| $1.11M | ﹤0.01% |
20,697
-516
| -2% | -$29K |
|
3319
BlackRock MuniAssets Fund
MUA
$521M
| $1.11M | ﹤0.01% |
102,310
+18,157
| +22% | +$200K |
|
3320
First Trust Dorsey Wright Dynamic Focus 5 ETF
FVC
$110M
| $1.1M | ﹤0.01% |
31,424
-5,040
| -14% | -$185K |
|
|
GGN
3321
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$831M
| $1.1M | ﹤0.01% |
251,961
+16,841
| +7% | +$69.4K |
|
3322
PUT
Hudbay
HBM
$11.9B
| $1.1M | ﹤0.01% |
+145,000
| New | +$1.18M |
|
|
PCN
3323
PIMCO Corporate & Income Strategy Fund
PCN
$879M
| $1.1M | ﹤0.01% |
80,579
-2,034
| -2% | -$27.7K |
|
3324
iShares MSCI Malaysia ETF
EWM
$330M
| $1.1M | ﹤0.01% |
47,597
+12,202
| +34% | +$289K |
|
3325
iShares High Yield Systematic Bond ETF
HYDB
$1.6B
| $1.1M | ﹤0.01% |
23,331
+5,084
| +28% | +$241K |
|
Similar funds
Royal Bank of Canada's Q1 2025 Portfolio in Review
As of Q1 2025, Royal Bank of Canada held 7,428 positions worth $479B, down 4.4% from $501B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q1 2025 filing shows 373 new, 3,020 increased, 3,038 reduced and 434 closed positions. Its largest new stake was Sandisk: 233,868 shares worth $11.1M. The largest sale was HCA Healthcare, an estimated $857M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q1 2025 buy was Sandisk: 233,868 shares worth $11.1M.
- Royal Bank of Canada added most to Canadian Natural Resources in Q1 2025, an estimated $1.33B increase.
- Royal Bank of Canada's biggest Q1 2025 reduction was HCA Healthcare, cutting an estimated $857M.
- Royal Bank of Canada fully exited Aspen Technology Inc in Q1 2025, selling an estimated $42.5M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $479B portfolio in Q1 2025.
- Royal Bank of Canada opened 373 new positions and closed 434 in Q1 2025.
- Royal Bank of Canada's portfolio value fell 4.4% quarter-over-quarter to $479B.
Based on Royal Bank of Canada's 13F filing for Q1 2025, filed 15 May 2025.